EMMANUEL Mignot is one of the world's leading experts on narcolepsy, a sleep disorder that he finds both "strange" and "fascinating."
The French-born Mignot has dedicated his life to studying the causes of narcolepsy and shedding light on one of the great biological mysteries -- sleep.
His discovery of the genetic and molecular causes of the disorder led to his receiving a prestigious Breakthrough Prize along with Japan's Masashi Yanagisawa, who made related findings around the same time.
Because of their discoveries, new treatments for narcolepsy -- which causes people to suddenly fall asleep -- and other sleep disorders are being developed.
About one in every 2,000 people suffers from narcolepsy. Some may experience catalepsy -- a sudden trance-like state.
"I am quite proud because what I have discovered is making an enormous difference for my patients," Mignot said in a telephone interview with AFP. "It's the best reward that one could receive."
The 63-year-old Mignot is a sleep researcher at Stanford University in California.
Thirty years ago, when he was a medical student, Mignot fulfilled his military service requirements in France by coming to Stanford to study a French-made drug that was being used to treat narcolepsy.
At the time, he said, the disease was "virtually unknown" and no one was actively studying it.
He became "completely fascinated."
"I told myself it's incredible, this disease, people fall asleep all the time, we have no idea why, and if we could discover the cause we might understand something new about sleep."
Stanford was already home to a renowned sleep center and its laboratory housed narcoleptic dogs, which Mignot began studying in an effort to find a genetic cause of the disease.
Genome sequencing was very primitive at that time and "everybody told me I was crazy," said Mignot, who currently has an adopted narcoleptic dog called Watson.
"I thought it would take a few years and it ended up taking 10."
In 1999, Mignot found a mutation in the genome of narcoleptic dogs. It was located on membrane receptors in the brain that respond to molecules outside the cell, similar to a lock and a key.
- 'Remake a key' -
The Japanese scientist Yanagisawa, meanwhile, had been studying orphan receptors -- receptors of unknown function -- in mice.
He discovered that a molecule that he named orexin binds to the same receptor Mignot detected as abnormal in dogs.
Mice who were deprived of orexin developed narcolepsy.
Mignot immediately began research on human subjects and found that orexin levels in the brain of narcolepsy patients were zero.
Normally, the molecule is produced in great quantities during the day, especially in the evening, allowing one to fight fatigue.
"You don't make a discovery like this twice in your life," Mignot said. "We found the cause of a disease.
"The advantage, is that we can remake a key," he said, referring to orexin.
For the moment, most patients are treated with a combination of powerful sedatives to help them sleep more soundly and amphetamines to keep them awake during the day.
Mignot said tests using a drug that mimics orexin have been "really miraculous."
Patients are fully awake and "transformed."
The challenge is to develop the right dose to be delivered at the right time.
Several companies, including Takeda of Japan, are working on it, and drugs could be authorized in the next few years.
They could be applied to other patients -- people suffering from depression, for example -- who have difficulty waking up, or to those in a coma.
Mignot meanwhile is studying whether narcolepsy may be caused by a flu virus.
The body's immune system may be confusing a flu virus with the cells that produce orexin and T-cells that fight infection are attacking them as a result.
"I've become interested in how the immune system works in the brain," a field he said is "beginning to explode."
As for sleep, Mignot remains fascinated by it even if he has uncovered one of the great mysteries.
"What is it that sleep does that it is so important that we have to do it every day?" he asked. "It's true that we still don't know."
ETX Studio
Sun Sep 25 2022
New treatments for narcolepsy which causes people to suddenly fall asleep and other sleep disorders are being developed. - ETX Studio
Pemain ragbi meninggal dunia selepas perlawanan pasukan pilihan MB Kedah
Seorang bekas pemain Sukma Kedah meninggal dunia selepas menyertai perlawanan pertunjukan pasukan pilihan Menteri Besar Kedah pada Ahad.
OCC: Masih banyak usaha perlu dibuat dalam isu hak kanak-kanak
Masih banyak yang perlu dilakukan kerana Malaysia masih ketinggalan berbanding negara lain dalam menangani isu penderaan dan masalah sosial melibatkan kanak-kanak.
iPad Pro mungkin dijana dengan cip Apple M4 terbaharu, fokus ciri AI
Cip Apple M4 dijangka memfokuskan kepada keupayaan enjin neural yang disertakan bersama dengannya membolehkan ia menawarkan ciri AI yang lebih baik.
Lebih 840,000 permohonan untuk London Marathon 2025 pecah rekod dunia
Jumlah permohonan untuk menyertai larian TCS London Marathon tahun depan telah memecahkan rekod dunia.
WEF: Anwar jumpa 50 pemimpin industri & perniagaan, yakin pelabur bernilai tinggi pilih Malaysia
Datuk Seri Anwar Ibrahim menzahirkan keyakinan lebih banyak pelabur bernilai tinggi akan memilih Malaysia sebagai destinasi pelaburan mengikut jejak langkah syarikat-syarikat gergasi seperti Tesla, AWS, Infineon dan Nvidia.
AWANI Ringkas: Ikut jejak syarikat gergasi lain
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Bursa Malaysia dibuka tinggi seiring prestasi Wall Street
Bursa Malaysia dibuka rendah pada Isnin, mengambil petunjuk pasaran serantau dan kenaikan di Wall Street pada hari Jumaat.
Kementerian Perpaduan kaji keperluan pelan tindakan pendidikan & penghargaan Rukun Negara
Kementerian Perpaduan Negara melalui Jabatan Perpaduan dan Integrasi Nasional akan mengkaji keperluan untuk melancarkan Pelan Tindakan Pendidikan & Penghargaan Rukun Negara sejajar dengan Dasar Perpaduan Negara 2021-2030.
Akta pekerjaan bagi lindungi pekerja OKU/Autistik diperlukan
Beatrice yang juga merupakan individu autistik berkata, bagi mengadakan akta atau menggubal dasar berkaitan, kerajaan perlu libatkan lebih banyak golongan autistik sebagai pemegang taruh utama.
Mesyuarat FOMC: The Fed dijangka kekalkan kadar faedah Mei 2024
Ketua Ekonomi Bank Muamalat Malaysia Bhd, Dr Mohd Afzanizam Abdul Rashid berkata, ia selepas unjuran awal beberapa pakar ekonomi melihat The Fed masih belum cukup yakin dengan usaha menurunkan kadar inflasi di negara itu.